Loading...
Larimar Therapeutics Inc (LRMR) is not a strong buy for a beginner, long-term investor at this moment. The technical indicators are bearish, options data shows limited trading interest, and the financial performance remains weak. There are no significant positive catalysts or news to support a buy decision.
The technical indicators are bearish. The MACD histogram is negative and contracting, RSI is neutral at 41.634, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 2.963 and resistance at 3.414.

NULL identified. There is no recent news, no significant hedge fund or insider trading activity, and no congress trading data.
EPS remains negative at -0.
Technical indicators are bearish, and there is an 80% probability of a -1.59% decline in the next day.
In Q3 2025, the company reported no revenue growth (0% YoY), a net loss of -$47.71 million (up 207.84% YoY), and an EPS of -0.61 (up 154.17% YoY). Gross margin remains at 0%.
No recent analyst ratings or price target changes are available for LRMR.